Tralokinumab: IL-13 Inhibition for Atopic Dermatitis

Overview / Definition Atopic dermatitis (AD) is a chronic inflammatory skin condition characterized by intense pruritus, eczematous lesions, and dry skin. It is often associated with other atopic diseases such as asthma and allergic rhinitis. Tralokinumab is a human IgG4 monoclonal antibody that specifically targets and inhibits interleukin-13 (IL-13), a critical mediator in the inflammatory pathway of AD. Epidemiology AD is one of the most common skin disorders, affecting up to 20% of children and 3% of adults worldwide. The prevalence varies by age, with a higher incidence observed in infants and young children. Although it can resolve with age, many patients continue to experience symptoms into adulthood. Higher prevalence in urban vs. rural settings. Increased incidence in developed countries. Family history of atopy is a significant risk factor. Pathophysiology / Mechanism The pathophysiology of AD involves a complex interplay between genetic, environmental, and immunological factors. Dysregulation of the immune system leads to an overproduction of Th2 cytokines, including IL-4, IL-5, and IL-13. IL-13 plays a pivotal role in promoting inflammation, disrupting the skin barrier function, and contributing to the characteristic symptoms of AD. Tralokinumab functions by specifically binding to IL-13, preventing it from interacting with its receptor on target cells, thereby inhibiting the downstream signaling pathways that lead to inflammation and skin barrier dysfunction. Clinical Presentation Patients with atopic dermatitis typically present with: Intense pruritus, often worse at night. Erythematous, dry, and scaly patches, commonly located on flexural areas, face, and neck in children. Chronic lichenification in long-standing cases. Secondary infections due to scratching and skin barrier impairment. Diagnosis / Workup The diagnosis of AD is primarily clinical, based on history and physical examination. Key elements include: History of pruritus and typical distribu